Antineoplaston a10
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
3093 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 81 | 3 | 2 | 1 | 55 | 141 |
| Depression | D003863 | — | F33.9 | 2 | 3 | 4 | 1 | 77 | 86 |
| Pain | D010146 | EFO_0003843 | R52 | 6 | 3 | 1 | 5 | 46 | 61 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | 1 | 2 | 9 | 2 | 46 | 58 |
| Stroke | D020521 | EFO_0000712 | I63.9 | 2 | 1 | — | 1 | 54 | 58 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 4 | 4 | 2 | 4 | 39 | 52 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 7 | 4 | 1 | 4 | 38 | 52 |
| Cognitive dysfunction | D060825 | — | G31.84 | 1 | 2 | 2 | 1 | 37 | 43 |
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | 2 | 2 | 1 | 4 | 33 | 41 |
| Anxiety | D001007 | EFO_0005230 | F41.1 | — | — | — | 1 | 40 | 41 |
Show 163 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Obesity | D009765 | EFO_0001073 | E66.9 | 3 | 3 | 1 | — | 75 | 80 |
| Neoplasms | D009369 | — | C80 | 21 | 12 | 2 | — | 35 | 63 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 7 | 10 | 4 | — | 37 | 54 |
| Overweight | D050177 | — | E66.3 | — | 1 | 1 | — | 35 | 36 |
| Covid-19 | D000086382 | — | U07.1 | 2 | 9 | 9 | — | 9 | 27 |
| Prostatic neoplasms | D011471 | — | C61 | 7 | 5 | 1 | — | 15 | 27 |
| Schizophrenia | D012559 | EFO_0000692 | F20 | 2 | 1 | 3 | — | 18 | 23 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | 3 | — | 2 | — | 17 | 22 |
| Non-small-cell lung carcinoma | D002289 | — | — | 8 | 9 | 1 | — | 3 | 18 |
| Autism spectrum disorder | D000067877 | — | F84.0 | 1 | — | 1 | — | 15 | 17 |
Show 159 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Exercise | D015444 | EFO_0000483 | — | 2 | 1 | — | — | 45 | 47 |
| Lung neoplasms | D008175 | — | C34.90 | 9 | 11 | — | — | 7 | 23 |
| Cerebral palsy | D002547 | — | G80 | — | 1 | — | — | 20 | 21 |
| Lymphoma | D008223 | — | C85.9 | 5 | 17 | — | — | 1 | 20 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 5 | 1 | — | — | 14 | 20 |
| Aging | D000375 | GO_0007568 | R41.81 | 1 | 1 | — | — | 17 | 18 |
| Carcinoma | D002277 | — | C80.0 | 5 | 7 | — | — | 8 | 17 |
| Back pain | D001416 | — | M54 | 2 | 1 | — | — | 14 | 17 |
| Head and neck neoplasms | D006258 | — | — | 6 | 5 | — | — | 4 | 12 |
| Glioma | D005910 | EFO_0000520 | — | 6 | 6 | — | — | — | 11 |
Show 215 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Motor activity | D009043 | EFO_0003940 | — | 1 | — | — | — | 50 | 51 |
| Therapeutic equivalency | D013810 | — | — | 20 | — | — | — | — | 20 |
| Fatigue | D005221 | — | R53.83 | 1 | — | — | — | 18 | 19 |
| Psychotic disorders | D011618 | — | F20.81 | 1 | — | — | — | 15 | 16 |
| Fasting | D005215 | EFO_0002756 | — | 2 | — | — | — | 9 | 11 |
| Irritable bowel syndrome | D043183 | EFO_0000555 | K58 | 1 | — | — | — | 9 | 10 |
| Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | 3 | — | — | — | 6 | 9 |
| Lung diseases | D008171 | EFO_0003818 | J98.4 | 2 | — | — | — | 6 | 8 |
| Blood pressure | D001794 | EFO_0004325 | — | 1 | — | — | — | 7 | 8 |
| Inflammatory bowel diseases | D015212 | EFO_0003767 | — | 1 | — | — | — | 6 | 7 |
Show 84 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Sedentary behavior | D057185 | — | — | — | — | — | — | 16 | 16 |
| Psychological well-being | D000092862 | — | — | — | — | — | — | 15 | 15 |
| Inflammation | D007249 | MP_0001845 | — | — | — | — | — | 14 | 14 |
| Psychological stress | D013315 | — | — | — | — | — | — | 14 | 14 |
| Mental health | D008603 | EFO_0003935 | — | — | — | — | — | 14 | 14 |
| Fibromyalgia | D005356 | EFO_0005687 | M79.1 | — | — | — | — | 12 | 12 |
| Body weight | D001835 | EFO_0004338 | — | — | — | — | — | 12 | 12 |
| Health behavior | D015438 | — | — | — | — | — | — | 12 | 12 |
| Autistic disorder | D001321 | EFO_0003758 | F84.0 | — | — | — | — | 11 | 11 |
| Sleep | D012890 | GO_0030431 | — | — | — | — | — | 11 | 11 |
Show 940 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use